PreAsthmaControl (PAC)
Study identifier:SD-004-0299
ClinicalTrials.gov identifier:NCT00234390
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Prevention of Asthma in infants/young children - PAC
Medical condition
asthma
Phase
Phase 4
Healthy volunteers
No
Study drug
Pulmicort (budesonide) pMDI
Sex
All
Actual Enrollment
400
Study type
Interventional
Age
N/A - 6 Months
Date
Study Start Date: 01 Nov 1998
Primary Completion Date: -
Study Completion Date: 01 Dec 2004
Study design
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
AstraZeneca AB CNS Medical Science Director
AstraZeneca
